| Cas No. | Product Name | Other Name | Assay |
| 110567-21-0 | (1S-trans)-2-[(Phenylmethoxy)methyl]-3-cyclopenten-1-ol | Entecavir Intermediate | 95% |
| 110567-22-1 | (1S,2R,3S,5R)-3-(Phenylmethoxy)-2-[(phenylmethoxy)methyl]-6-oxabicyclo[3.1.0]hexane | Entecavir Intermediate | 95% |
| 142217-77-4 | (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol | Entecavir Intermediate | 99% |
| 142217-78-5 | (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol | Entecavir Intermediate | 99% |
| 142217-80-9 | 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine | Entecavir Intermediate | 98.50% |
| 204845-95-4 | 6-(Benzyloxy)-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-9H-purine-2-amine | Entecavir Intermediate | 99% |
| 142217-81-0 | 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one | Entecavir Intermediate | 99% |
| 106941-25-7 | 9-[2-Phosphonylmethoxyethyl]adenine; 2-(6-Amino-9H-purin-9-yl)ethoxy]methylphosphonic acid Adefovir(PMEA) | Adefovir Intermediate | 99% |
Products under Patent are not for ultimate sale in the country where patent has not expired. All liability for violation of Patent laws will be to the account of the Purchaser.
